BACKGROUND: The BIO14.6 hamster is an excellent animal model for inherited cardiomyopathy, because of its lethal and well-documented course, due to a spontaneous deletion of delta-sarcoglycan gene promoter and first exon. The muscle disease is progressive and average lifespan is 11 months, because heart slowly dilates towards heart failure. METHODOLOGY/PRINCIPAL FINDINGS: Based on the ability of adeno-associated viral (AAV) vectors to transduce heart together with skeletal muscle following systemic administration, we delivered human delta-sarcoglycan cDNA into male BIO14.6 hamsters by testing different ages of injection, routes of administration and AAV serotypes. Body-wide restoration of delta-SG expression was associated with functional reconstitution of the sarcoglycan complex and with significant lowering of centralized nuclei and fibrosis in skeletal muscle. Motor ability and cardiac functions were completely rescued. However, BIO14.6 hamsters having less than 70% of fibers recovering sarcoglycan developed cardiomyopathy, even if the total rescued protein was normal. When we used serotype 2/8 in combination with serotype 2/1, lifespan was extended up to 22 months with sustained heart function improvement. CONCLUSIONS/SIGNIFICANCE: Our data support multiple systemic administrations of AAV as a general therapeutic strategy for clinical trials in cardiomyopathies and muscle disorders.
BACKGROUND: The BIO14.6 hamster is an excellent animal model for inherited cardiomyopathy, because of its lethal and well-documented course, due to a spontaneous deletion of delta-sarcoglycan gene promoter and first exon. The muscle disease is progressive and average lifespan is 11 months, because heart slowly dilates towards heart failure. METHODOLOGY/PRINCIPAL FINDINGS: Based on the ability of adeno-associated viral (AAV) vectors to transduce heart together with skeletal muscle following systemic administration, we delivered humandelta-sarcoglycan cDNA into male BIO14.6 hamsters by testing different ages of injection, routes of administration and AAV serotypes. Body-wide restoration of delta-SG expression was associated with functional reconstitution of the sarcoglycan complex and with significant lowering of centralized nuclei and fibrosis in skeletal muscle. Motor ability and cardiac functions were completely rescued. However, BIO14.6 hamsters having less than 70% of fibers recovering sarcoglycan developed cardiomyopathy, even if the total rescued protein was normal. When we used serotype 2/8 in combination with serotype 2/1, lifespan was extended up to 22 months with sustained heart function improvement. CONCLUSIONS/SIGNIFICANCE: Our data support multiple systemic administrations of AAV as a general therapeutic strategy for clinical trials in cardiomyopathies and muscle disorders.
Authors: Paul Gregorevic; Michael J Blankinship; James M Allen; Robert W Crawford; Leonard Meuse; Daniel G Miller; David W Russell; Jeffrey S Chamberlain Journal: Nat Med Date: 2004-07-25 Impact factor: 53.440
Authors: Michael J Blankinship; Paul Gregorevic; James M Allen; Scott Q Harper; Hollie Harper; Christine L Halbert; A Dusty Miller; Dusty A Miller; Jeffrey S Chamberlain Journal: Mol Ther Date: 2004-10 Impact factor: 11.454
Authors: F Muntoni; M Cau; A Ganau; R Congiu; G Arvedi; A Mateddu; M G Marrosu; C Cianchetti; G Realdi; A Cao Journal: N Engl J Med Date: 1993-09-23 Impact factor: 91.245
Authors: T Ragot; N Vincent; P Chafey; E Vigne; H Gilgenkrantz; D Couton; J Cartaud; P Briand; J C Kaplan; M Perricaudet Journal: Nature Date: 1993-02-18 Impact factor: 49.962
Authors: K Matsumura; F M Tomé; H Collin; K Azibi; M Chaouch; J C Kaplan; M Fardeau; K P Campbell Journal: Nature Date: 1992-09-24 Impact factor: 49.962
Authors: Masahiko Hoshijima; Takeharu Hayashi; Young E Jeon; Zhenxing Fu; Yusu Gu; Nancy D Dalton; Mark H Ellisman; Xiao Xiao; Frank L Powell; John Ross Journal: Circ Heart Fail Date: 2010-10-29 Impact factor: 8.790
Authors: Roberta Fiaccavento; Felicia Carotenuto; Alba Vecchini; Luciano Binaglia; Giancarlo Forte; Enrico Capucci; Anna Maria Maccari; Marilena Minieri; Paolo Di Nardo Journal: Am J Pathol Date: 2010-09-09 Impact factor: 4.307